Prevalence and Clinical and Immunoviralogical Profile of Human Immunodeficiency Virus-Hepatitis B Coinfection among Children in an Antiretroviral Therapy Programme in Benue State, Nigeria
暂无分享,去创建一个
[1] W. Sadoh,et al. HIV co-infection with hepatitis B and C viruses among Nigerian children in an antiretroviral treatment programme , 2011 .
[2] U. Unicef,et al. Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011. , 2011 .
[3] J. Ndako,et al. Seroprevalence of Hepatitis B Surface Antigen (HBsAg) among Children of Primary School Age in a Community, North-Central, Nigeria , 2010 .
[4] E. Mbaawuaga,et al. Hepatitis B Virus (HBV) Infection among Pregnant Women in Makurdi, Nigeria. , 2010 .
[5] J. Goedert,et al. Hepatitis B viral load and risk for liver cirrhosis and hepatocellular carcinoma in The Gambia, West Africa , 2010, Journal of viral hepatitis.
[6] Shuntai Zhou,et al. Hepatitis B and Hepatitis C Seroprevalence in Children Receiving Antiretroviral Therapy for Human Immunodeficiency Virus-1 Infection in China, 2005-2009 , 2009, Journal of acquired immune deficiency syndromes.
[7] H. Abubakar,et al. Study of hepatic functions and prevalence of hepatitis B surface antigenaemia in Nigerian children with human immunodeficiency virus infection. , 2010, Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria.
[8] E. Ugwuja,et al. Seroprevalence of Hepatitis B Surface Antigen and Liver Function Tests among Adolescents in Abakaliki, South Eastern Nigeria , 2009 .
[9] M. Yuen,et al. Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B. , 2009, Journal of hepatology.
[10] C. Rouzioux,et al. Frequent occurrence of chronic hepatitis B virus infection among West African HIV type-1-infected children. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] M. Matee,et al. Seroprevalence of hepatitis B and C viral co-infections among children infected with human immunodeficiency virus attending the paediatric HIV care and treatment center at Muhimbili National Hospital in Dar-es-Salaam, Tanzania , 2007, BMC public health.
[12] M. Rosenberg,et al. Prevalence of hepatitis B and C virus infections in children infected with HIV. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[13] Julian Gold,et al. Antiretroviral therapy for HIV infection in infants and children: towards universal access. Recommendations for a public health approach. , 2007 .
[14] S. Akhtar,et al. Hepatitis B and C: prevalence and risk factors associated with seropositivity among children in Karachi, Pakistan , 2006, BMC infectious diseases.
[15] S. Lewin,et al. Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy , 2006, AIDS.
[16] A. Bassi,et al. Sero-prevalence of hepatitis B surface antigen among primary school pupils in rural Hawal valley, Borno State, Nigeria , 2005 .
[17] C. Quantin,et al. Acute Liver Enzyme Elevations in HIV-1-Infected Patients , 2003, HIV clinical trials.
[18] P. Klenerman,et al. Viral coinfections among African children infected with human immunodeficiency virus type 1. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] F. Callea,et al. Severe Hepatotoxicity During Combination Antiretroviral Treatment: Incidence, Liver Histology, and Outcome , 2003, Journal of acquired immune deficiency syndromes.
[20] Angyo Ia,et al. Lack of association between some risk factors and hepatitis B surface antigenaemia in children with sickle cell anaemia. , 2001 .
[21] I. Angyo,et al. Lack of association between some risk factors and hepatitis B surface antigenaemia in children with sickle cell anaemia. , 2001, West African journal of medicine.
[22] R. Chaisson,et al. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. , 2000, JAMA.
[23] D. Cooper,et al. Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR). The CAESAR Coordinating Committee. , 1999, The Journal of infectious diseases.
[24] M. Loriot,et al. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men , 1999, Hepatology.
[25] J. Oleske,et al. Guidelines for the use of antiretroviral agents in pediatric HIV infection , 1998 .
[26] R. Tedder,et al. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection , 1997, AIDS.
[27] H. Oshitani,et al. Prevalence of hepatitis B antigens in human immunodeficiency virus type 1 seropositive and seronegative pregnant women in Zambia. , 1996, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[28] P. Magnus,et al. Hepatitis B antibodies in HIV‐infected homosexual men are associated with more rapid progression to AIDS , 1992, AIDS.